retatrutide type 2 diabetes trial 2024 phase 2 results Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Efficacy and safety of retatrutide, – Eli Lilly infiltrates anti-obesity market

If you choose morning injection, the abdomen may be your most practical site since you can inject while standing at the bathroom mirror

In individuals without established CVD but with multiple cardiovascular risk factors (such as age 55 years, obesity, hypertension, smoking, dyslipidaemia or albuminuria), a GLP-1 RA with proven benefit could be used to reduce MACE, or an SGLT2i with proven benefit could be used to reduce MACE and HF and improve kidney outcomes

[10] It is also linked with anxiety, high blood pressure, rapid heartbeat, and insomnia

8 It is also responsible for determining how fat is metabolized in the liver and how it is stored in the body